Wearable Electrical Stimulation Device Shows Promise for Long COVID Relief

Study finds TENS therapy reduces pain, fatigue, and mobility issues in long COVID patients, though further research is needed.

A UCLA and Baylor College of Medicine study demonstrated that high-dose TENS therapy reduced pain by 26.1% and improved fast walking performance by 8% in long COVID patients.
The wearable Transcutaneous Electrical Nerve Stimulation (TENS) device uses low-voltage electrical currents to provide non-invasive, on-demand symptom relief.
Participants in the high-dose TENS group reported a higher perceived benefit (71.2%) compared to the placebo group (61.4%), highlighting its potential for symptom management.
Researchers emphasized the device's usability, as its wearable design allowed seamless integration into daily routines without disrupting activities.
While findings are promising, the study's small sample size necessitates further research to confirm the device's efficacy and explore broader applications for other chronic conditions.